Paradoxical roles for lysyl oxidases in cancer--a prospect.
about
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cellsNuclear translocation of lysyl oxidase is promoted by interaction with transcription repressor p66βPost-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cellsMegakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connectionMatrix crosslinking forces tumor progression by enhancing integrin signalingInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisCurrent Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survivalThe effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancer5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapyThe role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancerUnexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migrationAlternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across speciesThe lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cellsRemodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence.Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomasThe lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples.The extracellular matrix at a glance.Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomasLKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling.LOXL2 in epithelial cell plasticity and tumor progression.High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.Extracellular matrix genes as hypoxia-inducible targets.Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.Lysyl oxidase-like 3b is critical for cartilage maturation during zebrafish craniofacial development.Transcriptome analysis of PPARγ target genes reveals the involvement of lysyl oxidase in human placental cytotrophoblast invasionHypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formationLysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathwayNna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling.High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.Deregulation of FoxM1b leads to tumour metastasis.Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
P2860
Q24301022-CAA9401A-9973-4704-8AAB-C05E3D06C599Q24301964-0EE51047-279E-489F-A553-A20A58954B20Q24309073-9FC6A7DC-7593-4F13-BB5C-E5F79ACCB8F8Q24607513-9C521407-2471-49FF-9D8D-CE245D00065AQ24646370-2C668631-7DDE-4CCB-A228-F33F231E5066Q26767150-44D22385-5544-4DFE-904B-A7D1CA61B8FCQ27002209-27456542-B82C-4FF4-B1F0-799103A659AFQ28236372-48717601-799D-43CC-B0CA-D85D7FA40132Q28274238-362F49E7-FE20-4558-92FC-F3BAE7A26821Q28292415-C0FD32B2-F0E4-4A37-BA49-61619B0DEBC9Q28304399-43682398-F49F-44E7-9514-553F579926A0Q28565782-4FFF9F24-A437-4E34-AC97-37232D7A1804Q28576808-5A022E77-DC79-4E30-B278-23EAC21F0C4AQ30439639-04CF9793-EC0E-40FB-96F6-8BD53B736825Q30476541-F67837D4-2DD6-4922-820C-858F6CE0AD10Q30483094-A9B275AC-3E10-40CE-BB4B-74171C41BB8BQ30544282-21A1002E-6108-4C22-9776-AB2EB8B0E38AQ33673803-A63F30A6-24DE-400C-99E1-C85C0A316E6FQ33859309-9921CD30-8227-4D34-B948-6B5FFA4417CDQ34152843-9262A0B2-FF25-46C3-A83A-07E19959EC21Q34197948-105A207D-EDD6-4BCD-AA2F-14F97130F4BBQ34279063-A232083C-31C2-42C1-87B8-6924FA2C6634Q34303455-3CB74D49-BC5C-4AF9-BC5C-1F722AFD0CF4Q34355294-8E5AC62A-1225-4154-9944-23AE30E66329Q34371559-A596B5BF-7DBA-4670-A5B5-55E3C0A0C327Q34380963-3A9C88B4-0B2A-4F01-B2F2-6B101960D234Q34781591-F2EC964E-4E9A-4902-914D-D8019239974CQ34887552-9C5BCD41-2A55-4643-96CC-CA7833FD3DE5Q34949651-0AFF481C-C5E3-4FEB-ADBC-17CC61922C0DQ35050472-4D5E4D51-CE86-4DAC-913E-D8D135B1FF60Q35239845-B8557837-1D63-45FF-A8BE-A121418211F7Q35340591-B837EA3E-1918-422F-83FA-FDFECC774DD9Q35527142-8F8B2981-6415-4BCE-8408-CCB80D60940BQ35605895-12DC5DB8-4786-412E-82F6-5821F978658DQ35632587-46D21397-04FD-4124-9BC4-7516ECF1CA8BQ35688339-2411D4C5-FBAE-41BF-9173-7DF3AD60813DQ35821224-6496128D-4324-4A2E-841B-DC1F0C182F27Q36059910-76471E76-3405-42F4-A860-C5BC7ED53450Q36108360-0F5E1C67-8F13-43D3-8BB1-503719363444Q36165491-6F57CF30-994C-4AE9-B96E-46E73E8C1D84
P2860
Paradoxical roles for lysyl oxidases in cancer--a prospect.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@ast
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@en
type
label
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@ast
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@en
prefLabel
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@ast
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@en
P2093
P2860
P356
P1476
Paradoxical roles for lysyl oxidases in cancer--a prospect.
@en
P2093
Dawn A Kirschmann
Mary J C Hendrix
Stacey L Payne
P2860
P304
P356
10.1002/JCB.21371
P577
2007-08-01T00:00:00Z